266 related articles for article (PubMed ID: 28882621)
21. Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors.
Thommen DS; Schreiner J; Müller P; Herzig P; Roller A; Belousov A; Umana P; Pisa P; Klein C; Bacac M; Fischer OS; Moersig W; Savic Prince S; Levitsky V; Karanikas V; Lardinois D; Zippelius A
Cancer Immunol Res; 2015 Dec; 3(12):1344-55. PubMed ID: 26253731
[TBL] [Abstract][Full Text] [Related]
22. Coinhibitory receptors and CD8 T cell exhaustion in chronic infections.
Kuchroo VK; Anderson AC; Petrovas C
Curr Opin HIV AIDS; 2014 Sep; 9(5):439-45. PubMed ID: 25010894
[TBL] [Abstract][Full Text] [Related]
23. TIM-3 does not act as a receptor for galectin-9.
Leitner J; Rieger A; Pickl WF; Zlabinger G; Grabmeier-Pfistershammer K; Steinberger P
PLoS Pathog; 2013 Mar; 9(3):e1003253. PubMed ID: 23555261
[TBL] [Abstract][Full Text] [Related]
24. Expression of a broad array of negative costimulatory molecules and Blimp-1 in T cells following priming by HIV-1 pulsed dendritic cells.
Shankar EM; Che KF; Messmer D; Lifson JD; Larsson M
Mol Med; 2011; 17(3-4):229-40. PubMed ID: 21103670
[TBL] [Abstract][Full Text] [Related]
25. Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection.
Yamamoto T; Price DA; Casazza JP; Ferrari G; Nason M; Chattopadhyay PK; Roederer M; Gostick E; Katsikis PD; Douek DC; Haubrich R; Petrovas C; Koup RA
Blood; 2011 May; 117(18):4805-15. PubMed ID: 21398582
[TBL] [Abstract][Full Text] [Related]
26. Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.
Teigler JE; Zelinskyy G; Eller MA; Bolton DL; Marovich M; Gordon AD; Alrubayyi A; Alter G; Robb ML; Martin JN; Deeks SG; Michael NL; Dittmer U; Streeck H
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904197
[TBL] [Abstract][Full Text] [Related]
27. TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade
Ghosh S; Sharma G; Travers J; Kumar S; Choi J; Jun HT; Kehry M; Ramaswamy S; Jenkins D
Mol Cancer Ther; 2019 Mar; 18(3):632-641. PubMed ID: 30587557
[TBL] [Abstract][Full Text] [Related]
28. Not All Immune Checkpoints Are Created Equal.
De Sousa Linhares A; Leitner J; Grabmeier-Pfistershammer K; Steinberger P
Front Immunol; 2018; 9():1909. PubMed ID: 30233564
[TBL] [Abstract][Full Text] [Related]
29. PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells.
Stecher C; Battin C; Leitner J; Zettl M; Grabmeier-Pfistershammer K; Höller C; Zlabinger GJ; Steinberger P
Front Immunol; 2017; 8():572. PubMed ID: 28588576
[TBL] [Abstract][Full Text] [Related]
30. Revisiting immune exhaustion during HIV infection.
Khaitan A; Unutmaz D
Curr HIV/AIDS Rep; 2011 Mar; 8(1):4-11. PubMed ID: 21188556
[TBL] [Abstract][Full Text] [Related]
31. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
Jin HT; Anderson AC; Tan WG; West EE; Ha SJ; Araki K; Freeman GJ; Kuchroo VK; Ahmed R
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14733-8. PubMed ID: 20679213
[TBL] [Abstract][Full Text] [Related]
32. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
[TBL] [Abstract][Full Text] [Related]
33. Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes.
Kamal AM; Wasfey EF; Elghamry WR; Sabry OM; Elghobary HA; Radwan SM
Clin Biochem; 2021 Oct; 96():13-18. PubMed ID: 34217699
[TBL] [Abstract][Full Text] [Related]
34. Blockade of PD-1 and LAG-3 Immune Checkpoints Combined with Vaccination Restores the Function of Antiviral Tissue-Resident CD8
Roy S; Coulon PG; Prakash S; Srivastava R; Geertsema R; Dhanushkodi N; Lam C; Nguyen V; Gorospe E; Nguyen AM; Salazar S; Alomari NI; Warsi WR; BenMohamed L
J Virol; 2019 Sep; 93(18):. PubMed ID: 31217250
[TBL] [Abstract][Full Text] [Related]
35. Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients.
Sada-Ovalle I; Ocaña-Guzman R; Pérez-Patrigeón S; Chávez-Galán L; Sierra-Madero J; Torre-Bouscoulet L; Addo MM
J Int AIDS Soc; 2015; 18(1):20078. PubMed ID: 26486200
[TBL] [Abstract][Full Text] [Related]
36. Immune-Checkpoint Blockade Opposes CD8
Pfannenstiel LW; Diaz-Montero CM; Tian YF; Scharpf J; Ko JS; Gastman BR
Cancer Immunol Res; 2019 Mar; 7(3):510-525. PubMed ID: 30728151
[TBL] [Abstract][Full Text] [Related]
37. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.
Fromentin R; Bakeman W; Lawani MB; Khoury G; Hartogensis W; DaFonseca S; Killian M; Epling L; Hoh R; Sinclair E; Hecht FM; Bacchetti P; Deeks SG; Lewin SR; Sékaly RP; Chomont N
PLoS Pathog; 2016 Jul; 12(7):e1005761. PubMed ID: 27415008
[TBL] [Abstract][Full Text] [Related]
38. Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers.
Pombo C; Wherry EJ; Gostick E; Price DA; Betts MR
J Infect Dis; 2015 Nov; 212(9):1376-86. PubMed ID: 25883386
[TBL] [Abstract][Full Text] [Related]
39. Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection.
Sperk M; Domselaar RV; Neogi U
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987244
[TBL] [Abstract][Full Text] [Related]
40. Reversal of the CD8
Li J; Huang HH; Tu B; Zhou MJ; Hu W; Fu YL; Li XY; Yang T; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Zhen C; Shi M; Wang FS; Zhang C
Front Immunol; 2021; 12():687296. PubMed ID: 34177939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
